Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...

AstraZeneca (AZ) and Merck – known as MSD outside the US and Canada – have shared positive results from a late-stage study of ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Traditionally, stories include several key elements: characters, setting, plot and an inciting incident to catalyse the rest of the story through climax and resolution. Stories also have causality – ...

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active moderate-to-severe hidradenitis suppurativa (HS) in adults. Estimated to affect one in ...

AstraZeneca (AZ) and Amgen have shared positive results from a late-stage study of Tezspire (tezepelumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The phase 3 WAYPOINT trial ...

The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat acute lymphoblastic leukaemia (ALL). The CD19-directed CAR-T cell therapy has ...

Novartis and Schrödinger have entered into a research collaboration and licence agreement worth over $2.4bn to advance multiple drug candidates for Novartis to develop and commercialise. The alliance ...

Johnson & Johnson (J&J) has announced that its anti-FcRn antibody nipocalimab has become the first investigational therapy to be granted breakthrough therapy designation (BTD) by the US Food and Drug ...